A pilot open-label trial of minocycline in patients with autism and regressive features

Overview of attention for article published in Journal of Neurodevelopmental Disorders, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 484)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source

twitter: 10 X users

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 92 Mendeley

Summary Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie: Evidenzbericht

Cited by The Association of the Scientific Medical Societies in Germany on 24 Mar 2021

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie: Langfassung der Leitlinie "Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie"

Cited by The Association of the Scientific Medical Societies in Germany on 24 Mar 2021

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.